Finch Therapeutics Group, Inc. Profile Avatar - Palmy Investing

Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that i…

Biotechnology
US, Somerville [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of FNCH's Analysis
CIK: 1733257 CUSIP: 31773D101 ISIN: US31773D2009 LEI: - UEI: -
Secondary Listings
FNCH has no secondary listings inside our databases.